Correct Dosage of Trimethoprim/Sulfamethoxazole for Pediatric UTI
For pediatric urinary tract infections, trimethoprim/sulfamethoxazole should be dosed at 6-12 mg/kg trimethoprim and 30-60 mg/kg sulfamethoxazole per day divided into 2 doses. 1
Dosing Guidelines
- The FDA-approved dosage for children with urinary tract infections is 8 mg/kg trimethoprim and 40 mg/kg sulfamethoxazole per 24 hours, given in two divided doses every 12 hours 2
- The American Academy of Pediatrics recommends 6-12 mg/kg trimethoprim and 30-60 mg/kg sulfamethoxazole per day in 2 doses for pediatric UTI treatment 1
- This medication is not recommended for infants less than 2 months of age 2
Treatment Duration
- The total course of therapy should be 7 to 14 days 1
- Evidence shows that shorter courses (1-3 days) are inferior to the recommended 7-14 day range for febrile UTIs 1
- While single-dose regimens have shown effectiveness in clearing bacteria initially, they are associated with higher rates of recurrence (23%) compared to standard courses (2%) 3
Route of Administration
- Most children with UTI can be treated orally 1
- Parenteral administration should be considered for children who:
Special Considerations
- Local antimicrobial susceptibility patterns should guide empiric therapy choice 1
- Adjust therapy based on culture and sensitivity results when available 1
- For febrile infants with UTI, avoid nitrofurantoin as it does not achieve adequate serum and parenchymal concentrations to treat pyelonephritis 1
- Monitor for adverse effects:
Weight-Based Dosing Guide
For children 2 months and older with UTI 2:
- 22 lb (10 kg): 1 regular strength tablet (400 mg/80 mg) every 12 hours
- 44 lb (20 kg): 2 regular strength tablets or 1 double strength tablet every 12 hours
- 66 lb (30 kg): 3 regular strength tablets or 1.5 double strength tablets every 12 hours
Common Pitfalls
- Using inadequate treatment duration (less than 7 days) for febrile UTIs may lead to treatment failure 1
- Failing to adjust therapy based on local resistance patterns can result in treatment failure 1
- Using nitrofurantoin for febrile UTIs or pyelonephritis is inappropriate as it doesn't achieve adequate tissue concentrations 1
- Not considering renal function when dosing TMP-SMX can lead to toxicity in patients with impaired renal function 2